RxDoctor Payments Data

Kendra Lowing

Physician Assistant · Holland, MINPI 1710951488

Payments from drug & device makers

$294in general payments, 2019–2025

Across 15 payments — averaging $19.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$74
  • Sanofi$40
  • Insmed, Inc.$33
  • Grifols USA, LLC$31
  • AstraZeneca$30
  • Daiichi Sankyo Inc.$25
  • plus $61 from 3 others

What the payments were for

  • Food & beverage$294100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$294 in reported general payments places this provider in the 55th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$16,371
Medicare patients
114
Services billed
189

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter54$49,493
Spiriva RespimatTiotropium Bromide34$26,568
Breztri AerosphereBudesonide/Glycopyr/Formoterol27$17,746
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$11,313
DuleraMometasone/Formoterol18$9,283
SymbicortBudesonide/Formoterol Fumarate25$8,717
Incruse ElliptaUmeclidinium Bromide12$8,307
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate20$6,893
Fluticasone-SalmeterolFluticasone Propion/Salmeterol26$5,743
Albuterol Sulfate HfaAlbuterol Sulfate71$3,471
Fluticasone Propionate28$1,407
Ipratropium Bromide30$1,375
Montelukast Sodium40$615
Azithromycin59$592
Prednisone146$383

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Incruse Ellipta$74$57,80066 claims
Boehringer IngelheimSpiriva Respimat, Stiolto Respimat$21$37,88146 claims
AstraZenecaBreztri Aerosphere, Symbicort$30$26,46352 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Holland

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →